top of page

Investors Relation

Dental Services Market Size in the U.S. 2024 to 2033

The U.S. dental services market size was estimated at USD 154.96 billion in 2023 and is predicted to be worth around USD 259.93 billion by 2033, at a CAGR of 5.3% from 2024 to 2033.

us-dental-services-market-size.jpg

Dental Services Market Size Global 2024 to 2033

The global dental services market size accounted for USD 453.44 billion in 2023 and it is expected to hit around USD 731.59 billion by 2033, growing at a CAGR of 4.9% from 2024 to 2033.

Global-dental-services-market-size.jpeg

Are you NutreGenic's ideal investor?

 

Describing you as our ideal investor in three dimensions:

​

1. Personality

Our ideal investor shares a deep passion for innovation and healthcare advancements. They are forward-thinking and visionary, willing to support long-term growth rather than just short-term gains. With an empathetic mindset, they value the human element behind the business—especially how NutreGenic’s products improve the lives of patients and enhance dental practices. Their personality is collaborative, supporting the leadership team’s mission with trust and transparency.

​

2. Expertness

Our ideal investor has expertise in scaling health tech, life sciences, and the dental sectors. They understand the unique challenges of bringing science-backed innovations like NutreGenic's HGF-based xOralProducts to market. Their background might include investments in biotech, medtech, or health-focused products that required navigating complex regulatory landscapes, clinical trials, and building partnerships with medical professionals. They can offer strategic guidance on product commercialization, distribution, and market penetration.

​

3. PEK / Network Connection

Our ideal investor has a strong Professional Experience and Knowledge (PEK) in venture-backed life science startups. Additionally, their network is well-connected in the dental, medical, and health-tech industries. This investor can facilitate introductions to key opinion leaders, potential distribution partners, and high-impact PR outlets. Their network spans not only financial backers but also influencers who can help accelerate NutreGenic’s brand credibility and market adoption.

In essence, they are people-centric investors, aligning with NutreGenic's belief in building a robust, mission-driven team that drives both patient outcomes and dental practice success.

Watch NutreGenic 6-Minute Executive Summary

Watch NutreGenic 5-Minute Executive Summary

White Papers and 3rd Party Studies on Fibroblast Growth Factor Technologies and Breakthroughs in Dentistry

NutreGenic-PitchDeck.png

Disclaimer Statement

Confidentiality: The information contained in our presentations and investor's pitch deck is confidential and intended solely for the recipient. Unauthorized sharing, dissemination, or other use of this material is strictly prohibited and may be unlawful. Please confirm any necessary consents from legal@NutreGenic.com before disclosing any information herein.


Investment Advice: Our presentations does not constitute investment advice. Potential investors should consult with their financial advisors to ensure that the investment meets their individual needs and risk profile.
Forward-Looking Statements: Certain statements in our pitch deck may be forward-looking and involve substantial risks and uncertainties. Actual outcomes may differ materially from those projected in these forward-looking statements. We undertake no obligation to update any forward-looking statements.


Non-Disclosure Agreement: By accepting our presentation and pitch deck, you agree to keep all contents confidential as per a Non-Disclosure Agreement that may be in place between NutreGenic and yourself.

 

Unauthorized use or disclosure of this confidential information is strictly prohibited.


Legal: NutreGenic pitch deck is provided "as is," and NutreGenic makes no representations or warranties, express or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to the information presented. No content on documents and pitch deck should be considered a legal agreement or binding in any way.
      
Accredited Investor Requirement:

Please note that investment opportunities discussed in our presentations are available only to accredited investors. To qualify as an accredited investor, individuals must meet criteria established by the applicable securities laws, which generally include financial assets, net worth, income, or professional experience requirements that demonstrate the investor’s ability to bear the financial risks of the investment. By proceeding to engage with our investment materials, you affirm that you meet the qualifications of an accredited investor as defined by the relevant regulatory authorities of your country jurisdiction and the United States of America and the SEC.

​

​

NutreGenic-Oral-Sicences-Logo-TP-BlackSlogan.png
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube

Customer Service:

​

M-F 9am-5pm PST

 

+1-307-206-0453

​

CS@NutreGenic.com

 

info@NutreGenic.com

 

Press@NutreGenic.com

 

Invest@NutreGenic.com â€‹â€‹â€‹

​​

Headquarters:

​

NutreGenic Oral Sciences, Inc.

30 N Gould St Suite N

Sheridan WY 82801 USA​

Copyright © 2023-2025 NutreGenic Oral Sciences Inc., All Rights Reserved Worldwide.

​

By using our site, and products, you acknowledge that you have read and understand our FDA Disclaimer Statement, Statement of Use,  Cookie Policy, Privacy Policy, Returns and Refunds and our Terms of Service.

​

NutreGenic Statement of Use

IronClad 60 Days Money Back Guarantee

​

The use of NutreGenic products is voluntarius. Upon request we provide full refund within 60 days of purchase. To request a refund please send an email, include your invoice details, and contact information to: CS@NutreGenic.com 

​

NutreGenic products described here are intended to meet the FDA’s definition of dietary supplements. The NutreGenic products are made in the USA and in the GMP compliant facilities.

 

Contact Us

Disclaimer and FDA

Statement

​

These statements have not been evaluated by the Food and Drug Administration. NutreGenic's products are not intended to diagnose, treat, cure or prevent any disease.

 

The views and nutritional advice expressed by NutreGenic and any of its Subsidiaries, employees, agents, and affiliates are not intended for the purpose of providing medical advice. Please always consult your health care provider if you are taking any medications or have any medical conditions. Individual results may vary.

bottom of page